TipRanks
Jeil Pharmaceutical Co. Ltd. (KR:271980)
:271980
South Korea Market
271980
Jeil Pharmaceutical Co. Ltd.
RESEARCH TOOLSreports

Jeil Pharmaceutical Co. Ltd. (271980) Financial Statements

― Followers

Jeil Pharmaceutical Co. Ltd. Financial Overview

Jeil Pharmaceutical Co. Ltd.'s market cap is currently ₩146.01B. The company's EPS TTM is ₩1215.67; its P/E ratio is 8.19; and it has a dividend yield of 0.30%. Jeil Pharmaceutical Co. Ltd. is scheduled to report earnings on August 14, 2026, and the estimated EPS forecast is ₩―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 566.34B₩ 704.54B₩ 726.39B₩ 722.23B₩ 700.69B
Gross Profit₩ 208.38B₩ 177.49B₩ 184.26B₩ 156.80B₩ 155.98B
Operating Income₩ 20.33B₩ -18.93B₩ 8.73B₩ -13.50B₩ -10.39B
EBITDA₩ 32.65B₩ -10.61B₩ 17.72B₩ -1.21B₩ -2.02B
Net Income₩ 23.38B₩ -29.97B₩ 5.00B₩ -13.09B₩ -12.47B
Balance Sheet
Cash & Short-Term Investments₩ 58.83B₩ 57.46B₩ 35.66B₩ 31.59B₩ 28.00B
Total Assets₩ 510.57B₩ 525.70B₩ 487.33B₩ 456.89B₩ 426.49B
Total Debt₩ 93.42B₩ 75.70B₩ 71.17B₩ 50.35B₩ 47.80B
Net Debt₩ 44.54B₩ 22.22B₩ 38.18B₩ 18.90B₩ 14.39B
Total Liabilities₩ 259.55B₩ 306.38B₩ 330.29B₩ 301.29B₩ 259.14B
Stockholders' Equity₩ 211.07B₩ 188.15B₩ 158.57B₩ 157.91B₩ 168.21B
Cash Flow
Free Cash Flow₩ -13.72B₩ -3.40B₩ -14.56B₩ -32.11B₩ 13.71B
Operating Cash Flow₩ -5.69B₩ 3.21B₩ -4.98B₩ -15.15B₩ 19.10B
Investing Cash Flow₩ -15.34B₩ -7.30B₩ -11.92B₩ -12.92B₩ -8.04B
Financing Cash Flow₩ 17.05B₩ 23.06B₩ 18.77B₩ 33.62B₩ 11.07B
Currency in KRW

Jeil Pharmaceutical Co. Ltd. Earnings and Revenue History

Income Statement >

Jeil Pharmaceutical Co. Ltd. Debt to Assets

Balance Sheet >

Jeil Pharmaceutical Co. Ltd. Cash Flow

Cash Flow >

Jeil Pharmaceutical Co. Ltd. Forecast EPS vs Actual EPS

Earnings >